Sharathchandra S Hegde Net Worth & Insider Trades

Sharathchandra S Hegde - SVP, Theravance Biopharma, Inc

As of May 22, 2019

What is Sharathchandra S Hegde's Net Worth?

The current estimated net worth of Theravance Biopharma, Inc's SVP, Sharathchandra S Hegde, is estimated to be about $2.92M . Sharathchandra S Hegde owns about 264,444 units of Theravance Biopharma, Inc common stock. In the last 3 years at Theravance Biopharma, Inc, Sharathchandra S Hegde has sold an estimated value of $1.7M worth.

What is Sharathchandra S Hegde's Past Insider Trading?

Sharathchandra S Hegde's largest sale order was 9,033 units , worth over $223.17K on March 6, 2019. In total, Sharathchandra S Hegde has made about 14 transactions over 3 years of their time at Theravance Biopharma, Inc. Sharathchandra S Hegde usually trades in February, with the busiest year in 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SHARATHCHANDRA HEGDE

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Sharathchandra S Hegde's' Mailing Address?

  • Mailing address is 901 Gateway Blvd South San Francisco CA 94080 CA

Theravance Biopharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick E Winningham 2020 $1,014,455 - $579,646 - $579,646 $6,045 $6,577,746
Rick E Winningham 2019 $983,710 - $473,906 - $473,906 $5,496 $5,932,411
Rick E Winningham 2018 $956,600 $74,767 $690,154 - $690,154 $5,000 $2,522,841
Andrew A. Hindman 2020 $551,608 - $265,278 - $265,278 $5,920 $2,097,950
Andrew A. Hindman 2019 $315,000 $175,000 $216,000 $2,204,956 $216,000 - $3,757,956
Brett Haumann 2020 $572,569 - $213,589 - $213,589 $53,267 $2,742,625
Brett Haumann 2019 $543,047 - $170,000 - $170,000 $42,382 $2,464,280
Brett Haumann 2018 $497,810 $34,125 $315,000 - $315,000 $414,300 $1,517,194
Vijay Sabesan 2020 $407,677 - $760,326 - $760,326 $6,541 $3,077,744
Bradford J. Shafer 2020 $556,321 - $264,999 - $264,999 $6,045 $2,730,565
Bradford J. Shafer 2019 $537,403 - $215,611 - $215,611 $6,983 $2,468,848
Bradford J. Shafer 2018 $518,080 $33,770 $311,726 - $311,726 $5,000 $1,124,537
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm

What are Theravance Biopharma, Inc's Past Insider Trades?

Theravance Biopharma, Inc's most recent insider trade came on November 22, 2023 by Rhonda Farnum who sold 9,360 units worth $96.95K . In the last 8 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $152.42M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP,  Rick Winningham, CHIEF EXECUTIVE OFFICER,  and Richard Graham, SVP .

Theravance Biopharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...